Faculty

Institution

Unit

Venue

Eli Gilboa

Professor Emeritus

University of Miami

Affiliations

Miller School of Medicine

Microbiology and Immunology

The Graduate School

Eli Gilboa is currently serving as a Microbiology And Immunology Professor Emeritus at University of Miami.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Eli Gilboa

University of Miami

Professor Emeritus

You can click a keyword to filter the displayed items

immunology oncology medicine cancer immunotherapy cancer research medicinal research pharmacology immunotherapy virology cell biology cancer treatment cancer biology tumor biology gene expression immune responses cellular therapy gene transfer clinical immunology viral genetics adaptive immune system cancer care rna biology virus research tumor targeting dendritic cells leukemia viral oncology molecular immunology cellular immune responses experimental medicine mammalian biology molecular cancer medical virology viral pathogenesis pharmacotherapy gene delivery general virology animal biotechnology cytokines viral replication viral evolution molecular virology t-regulatory cell cancer genomics tumor cells antitumor immunity enzyme inhibition experimental biology host specificity virus transmission innate immune system immunomodulation clinical investigation cell transplantation clinical microbiology cell therapy vaccine research virus-host interactions retroviral vectors tumor immunity clinical medicine immunotoxicology lymphoid neoplasia tumor immunotherapy molecular biotechnology genome structure human dendritic cells reverse transcription lymphoid cells mammalian cells autologous dendritic cells tumor extracts gene-modified tumor cells bladder tumors cell-free translation fibroblast activation protein mrna vaccines hiv antiviral research gene therapy human retrovirus

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Vaccination Against Neoantigens Induced in Cross-Priming Cdc1 in Vivo. Cancer Immunology Immunotherapy (2024)

Emily S. ClarkAna Paula BenaduceWasif N. KhanOlivier MartinezEli Gilboa

cancer immunotherapyimmunologyvaccinationimmunotherapyin vivo systems

Data From Radiation-Induced Enhancement of Antitumor T-Cell Immunity by Vegf-Targeted 4-1Bb Costimulation. (2023)

Brett SchrandBhavna VermaAgata LevayShradha PatelIris CastroAna Paula BenaduceRandall BrennemanOliver UmlandHideo YagitaEli GilboaAdrian Ishkanian

radiation-induced enhancementradiation oncologyradiation biologycancer immunotherapyimmunologydosimetrycancer researchantitumor t-cell immunityradiationcancer treatmentoncology

Data From Targeting 4-1Bb Costimulation to the Tumor Stroma With Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy. (2023)

Brett SchrandAlexey BerezhnoyRandall BrennemanAnthony WilliamsAgata LevayLing-Yuan KongGanesh RaoShouhao ZhouAmy B. HeimbergerEli Gilboa

anti-cancer agentsdrug targetingimmunologydermatologypharmacologytherapeutic targetstherapeutic indexbispecific aptamer conjugatescancer immunotherapyimmunotherapycancer researchcancer treatmentcancer cellstumor immunotherapytumor stromamedicinal researchbiomarker targetmolecular cancercellular therapyoncologyleukemiatherapeutic efficacy

Data From Vaccination Against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. (2023)

Greta GarridoBrett SchrandAgata LevayAilem RabasaAnthony FerrantellaDiane M. Da SilvaFrancesca D'EramoKoen A. MarijtZhuoran ZhangDeukwoo KwonMarcin KortylewskiW. Martin KastVikas DudejaThorbald van HallEli Gilboa

public healthfuture tumorsvaccinesvaccinationimmunologycancer researchmedicineoncologycancer biology

Remodeling of Stromal Immune Microenvironment by Urolithin a Improves Survival With Immune Checkpoint Blockade in Pancreatic Cancer. Cancer research communications (2023)

Siddharth MehraVanessa T. GarridoAustin R. DoschPurushottam LamichhaneSupriya SrinivasanSamara P. SinghZhiqun ZhouIago De Castro SilvaChandrashekar JoshiYuguang BanJashodeep DattaEli GilboaNipun B. MerchantNagaraj S. Nagathihalli

immune checkpoint blockadeimmunologythoracic oncologycancer immunotherapystromal immune microenvironmentcancer preventionimmunotherapycancer researchpancreatic cancercancer treatmenthealth sciencesmedicinal researchimproves survivalcancer carecancer managementcancer biologymedicinesurvival analysisoncology

Supplementary Tables S1-S2 From Remodeling of Stromal Immune Microenvironment by Urolithin a Improves Survival With Immune Checkpoint Blockade in Pancreatic Cancer. (2023)

immune checkpoint blockadecancer immunotherapyimmunologymedicinal researchcancer preventionimmunotherapystromal immune microenvironmentcancer researchimmune checkpoint inhibitorspancreatic cancerpharmacologytherapeutic efficacyimproves survivaltumor microenvironmentcancer treatmentcancer careoncology

The Quest for Mrna Vaccines. Nucleic Acid Therapeutics (2022)

Eli GilboaDavid BoczkowskiSmita K. Nair

gene therapyvaccine developmentnucleic acidsmrna vaccinesvaccine researchmolecular biologymedicinerna biologygenetics

Aptamer-Mediated Transcriptional Gene Silencing of Foxp3 Inhibits Regulatory T Cells and Potentiates Antitumor Response. Molecular Therapy — Nucleic Acids (2021)

Andrea J. Manrique-RincónLuciana P. RuasCarolinne T. FogagnoloRandall J. BrennemanAlexey BerezhnoyBianca CastelucciSílvio R. ConsonniEli GilboaMarcio C. Bajgelman

molecular immunologytumor biologycancer immunotherapyimmunologynucleic acidstumor suppressorstranscription regulationmedicinemolecular biologygene expressioncell regulationgene regulatory networksoncology

Author Correction: Hapten-Mediated Recruitment of Polyclonal Antibodies to Tumors Engenders Antitumor Immunity. Nature Communications (2021)

Brett SchrandEmily ClarkAgata LevayAilem Rabasa CapoteOlivier MartinezRandall BrennemanIris CastroEli Gilboa

polyclonal antibodieshapten-mediated recruitmenttumor biologycancer immunotherapyimmunologymedicinal researchviral oncologydermatologyimmunotherapyantibody engineeringimmune mediatorscancer researchtumor suppressorsauthor correctionpharmacologyoncology

Immune Modulatory Short Noncoding Rnas Targeting the Glioblastoma Microenvironment. Frontiers in Oncology (2021)

Jun WeiEli GilboaGeorge A. CalinAmy B. Heimberger

immune modulatorycancer immunotherapyglioblastoma microenvironmentimmunologymedicinal researchneurosciencebrain tumor researchcellular therapycancer researchimmune responsescellular immune responsesmedicineadaptive immune systembrain-immune interactiontumor microenvironmentrna biologyoncologycancer biology

1
2
3
4
5
21
10 / page

Eli Gilboa

Professor Emeritus

University of Miami

Affiliations

Miller School of Medicine

Microbiology and Immunology

The Graduate School

Eli Gilboa is currently serving as a Microbiology And Immunology Professor Emeritus at University of Miami.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Eli Gilboa

University of Miami

Professor Emeritus

You can click a keyword to filter the displayed items

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Vaccination Against Neoantigens Induced in Cross-Priming Cdc1 in Vivo. Cancer Immunology Immunotherapy (2024)

Emily S. ClarkAna Paula BenaduceWasif N. KhanOlivier MartinezEli Gilboa

cancer immunotherapyimmunologyvaccinationimmunotherapyin vivo systems

Data From Radiation-Induced Enhancement of Antitumor T-Cell Immunity by Vegf-Targeted 4-1Bb Costimulation. (2023)

Brett SchrandBhavna VermaAgata LevayShradha PatelIris CastroAna Paula BenaduceRandall BrennemanOliver UmlandHideo YagitaEli GilboaAdrian Ishkanian

radiation-induced enhancementradiation oncologyradiation biologycancer immunotherapyimmunologydosimetrycancer researchantitumor t-cell immunityradiationcancer treatmentoncology

Data From Targeting 4-1Bb Costimulation to the Tumor Stroma With Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy. (2023)

Brett SchrandAlexey BerezhnoyRandall BrennemanAnthony WilliamsAgata LevayLing-Yuan KongGanesh RaoShouhao ZhouAmy B. HeimbergerEli Gilboa

Data From Vaccination Against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. (2023)

public healthfuture tumorsvaccinesvaccinationimmunologycancer researchmedicineoncologycancer biology

Remodeling of Stromal Immune Microenvironment by Urolithin a Improves Survival With Immune Checkpoint Blockade in Pancreatic Cancer. Cancer research communications (2023)

Supplementary Tables S1-S2 From Remodeling of Stromal Immune Microenvironment by Urolithin a Improves Survival With Immune Checkpoint Blockade in Pancreatic Cancer. (2023)

The Quest for Mrna Vaccines. Nucleic Acid Therapeutics (2022)

Eli GilboaDavid BoczkowskiSmita K. Nair

gene therapyvaccine developmentnucleic acidsmrna vaccinesvaccine researchmolecular biologymedicinerna biologygenetics

Aptamer-Mediated Transcriptional Gene Silencing of Foxp3 Inhibits Regulatory T Cells and Potentiates Antitumor Response. Molecular Therapy — Nucleic Acids (2021)

Andrea J. Manrique-RincónLuciana P. RuasCarolinne T. FogagnoloRandall J. BrennemanAlexey BerezhnoyBianca CastelucciSílvio R. ConsonniEli GilboaMarcio C. Bajgelman

Author Correction: Hapten-Mediated Recruitment of Polyclonal Antibodies to Tumors Engenders Antitumor Immunity. Nature Communications (2021)

Brett SchrandEmily ClarkAgata LevayAilem Rabasa CapoteOlivier MartinezRandall BrennemanIris CastroEli Gilboa

Immune Modulatory Short Noncoding Rnas Targeting the Glioblastoma Microenvironment. Frontiers in Oncology (2021)

Jun WeiEli GilboaGeorge A. CalinAmy B. Heimberger

1
2
3
4
5
21
10 / page

Similar Faculty Members

Kai Wucherpfennig

Institution

Harvard University

immunology

immune responses

Jenny Ting

Institution

University of North Carolina at Chapel Hill

gene discovery

innate immune system

Kamel Khalili

Institution

Temple University

neuroscience

neurodegenerative disease

Bruce L. Levine

Institution

University of Pennsylvania

gene therapy

cell therapy

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Edgar Engleman

Institution

Stanford University

cellular therapy

immune response

Christopher H. Contag

Institution

Stanford University

immunology

biomedical imaging

Smita K Nair

Institution

Duke University

therapeutic vaccine

immunomodulation

Darrell J. Irvine

Institution

Massachusetts Institute of Technology

immunology

immune responses

Elizabeth Thompson

Institution

Johns Hopkins University

histopathology

immunology

Similar Faculty Members

Kai Wucherpfennig

Institution

Harvard University

immunology

immune responses

Jenny Ting

Institution

University of North Carolina at Chapel Hill

gene discovery

innate immune system

Kamel Khalili

Institution

Temple University

neuroscience

neurodegenerative disease

Bruce L. Levine

Institution

University of Pennsylvania

gene therapy

cell therapy

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Edgar Engleman

Institution

Stanford University

cellular therapy

immune response

Christopher H. Contag

Institution

Stanford University

immunology

biomedical imaging

Smita K Nair

Institution

Duke University

therapeutic vaccine

immunomodulation

Darrell J. Irvine

Institution

Massachusetts Institute of Technology

immunology

immune responses

Elizabeth Thompson

Institution

Johns Hopkins University

histopathology

immunology